Clearmind Medicine CMND
NASDAQ CMND
$0.81 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Clearmind Medicine (CMND) Non Operating Income (2023)

Updated

Clearmind Medicine (CMND) posted Non Operating Income of -$4,099 for fiscal Q2 2023 (quarter ended Apr 30, 2023).

Analysis

Clearmind Medicine (CMND) Non Operating Income (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Clearmind Medicine 10,294.29 10,294.29 - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2023 -4,098.77
Jan 31, 2023 16,385.56
API Access

Clearmind Medicine Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=CMND&period=max&api_key=YOUR_API_KEY